Determination of the value of a centralized iodine prevention of the Precarpathian population


  • I. O. Fedyak SHHE «Ivano-Frankivsk National Medical University», Ukraine
  • A. Yu. Pustovit SHHE «Ivano-Frankivsk National Medical University», Ukraine



iodine deficiency, iodine medicines, antistrumin, marketing analysis, cost of iodine prevention


The analysis of registration of H03C group in the State Register of Drugs in Ukraine has revealed that as of 01.01.2014, there were 6 registered drugs for prevention of iodine deficiency, and 2 of them were produced abroad. As of 25.10.2014, there were only 3 drugs at the pharmaceutical market of Ukraine – Antistrumin (Darnitsya, Ukraine) Yodomaryn (Berlin-Chemie, Germany), Iodide (Farmak, Ukraine). The results of monthly monitoring of the average wholesale price show that their values in 2013 did not change significantly. However, in March and April 2014 there was a sharp increase in prices (the average price of the German drug Yodomaryn increased by more than one and half) due to introduction of 7% VAT on medicines, as well as depreciation of the hryvnia’s official exchange rate at the foreign exchange market. The estimated average annual values of liquidity ratios indicate that the price range for such drug as Yodomaryn 200 mcg № 50, Berlin-Chemie, Germany, depending on the suppliers cannot be considered valid and ethical in relation to the solvency of the citizens of Ukraine. To provide the needs of iodine prevention of the population at large at the expense of local budgets in the Ivano-Frankivsk region, 8 million 557 thousand UAH is needed. In the presence of state of local regional budgets deficit it is reasonable to recommend funding for prevention of endemic goiter at least for children under the age of 14 years; therefore, the Ivano-Frankivsk region should be provided by 1,010,238,24 UAH.


Наказ МОЗ України від 11.10.2013 р. №875 «Про затвердження протоколів провізора (фармацевта)».

Шідловський В.О., Дейкало І.М. Йододефіцитні захворювання: діагностика, лікування, профілактика. – Тернопіль: Укрмедкнига, 2006. – 124 с.

Bürgi H., Supersaxo Z., Selz B. // Acta Endocrinol. – 1990. – №123. – P. 577-590.

Delange F., Dunn J., Glinoer D. Iodine deficiency in Europe. A continuing concern. – New York: Plenum Press, 1993. – P. 456.

Lyn Patrick // Alternative Medicine Rev. – 2008. – №13 (2). – P. 116-127.

Shakhtarin V.V., Tsyb A.F., Stepanenko V.F. // Int. J. Epidemiol. – 2003. – №32. – P. 584-591.

UNICEF Office for Bosnia-Herzergovina. Iodine status of the population of Bosnia-Herzergovina. – Sarajevo, United Nations Children’s Fund. – 2006. – 15 p.

Wolff J. // Medicine. – 2001. – №80. – P. 20-36.

Zamrazil V. // Thyroid. – 2004. – №14. – P. 49-56.

Zimmermann M.B. // Endocrine Rev. – 2009. – Vol. 30 (4). – P. 376-408.